MicroPort Scientific Corporation (HKG:0853)
Hong Kong · Delayed Price · Currency is HKD 7.52
+0.12 (1.62%)
May 29, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Cardiovascular Devices Business | 182.18M | 165.74M | - | - | - | |||||
Cardiovascular Devices Business Growth | 9.92% | - | - | - | - | |||||
Orthopedics Devices Business | 235.16M | 252.71M | 238.37M | 225.34M | 215.61M | |||||
Orthopedics Devices Business Growth | -6.95% | 6.02% | 5.78% | 4.51% | 6.95% | |||||
Cardiac Rhythm Management (CRM) Business | 229.72M | 220.61M | 207.04M | 205.18M | 220.42M | |||||
Cardiac Rhythm Management (CRM) Business Growth | 4.13% | 6.56% | 0.91% | -6.91% | 22.25% | |||||
Endovascular and Peripheral Vascular Devices Business | 189.48M | 169.54M | 168.22M | 133.27M | 106.03M | |||||
Endovascular and Peripheral Vascular Devices Business Growth | 11.76% | 0.78% | 26.23% | 25.69% | 54.81% | |||||
Structural Heart Disease Business | 51.31M | 50.70M | 47.52M | 37.02M | 31.32M | |||||
Structural Heart Disease Business Growth | 1.22% | 6.70% | 28.36% | 18.17% | 106.02% | |||||
Surgical Robot Business | 77.58M | 36.02M | 14.81M | 3.09M | 329.00K | |||||
Surgical Robot Business Growth | 115.35% | 143.29% | 378.85% | 839.82% | - | |||||
Others | 95.61M | 51.72M | 28.07M | 21.77M | 1.60M | |||||
Others Growth | 84.84% | 84.30% | 28.90% | 1259.11% | 96.81% | |||||
Neurovascular Devices Business - Discontinued Operation | 111.04M | 106.98M | - | - | - | |||||
Neurovascular Devices Business - Discontinued Operation Growth | 3.79% | - | - | - | - | |||||
Elimination of Intersegment | -66.69M | -22.95M | -11.69M | -16.20M | - | |||||
Cardiovascular Devices Business (Excluding CRM & Surgical Robot Device & Heart Valve Business) | - | - | 156.47M | 146.65M | 139.54M | |||||
Cardiovascular Devices Business (Excluding CRM & Surgical Robot Device & Heart Valve Business) Growth | - | - | 6.69% | 5.10% | -3.61% | |||||
Neurovascular Devices Business | - | - | 94.17M | 80.20M | 59.05M | |||||
Neurovascular Devices Business Growth | - | - | 17.41% | 35.81% | 79.31% | |||||
Surgical Devices Business | - | - | 7.76M | 4.51M | 4.73M | |||||
Surgical Devices Business Growth | - | - | 72.05% | -4.57% | 2.16% | |||||
Total | 1.11B | 1.03B | 950.73M | 840.83M | 778.64M | |||||
Total Growth | 7.21% | 8.45% | 13.07% | 7.99% | 20.02% |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
The People's Republic of China (The PRC) | 518.95M | 522.11M | 492.79M | 405.64M | 356.98M | |||||
The People's Republic of China (The PRC) Growth | -0.61% | 5.95% | 21.49% | 13.63% | 23.35% | |||||
North America | 82.27M | 92.41M | 99.93M | 96.46M | 94.98M | |||||
North America Growth | -10.97% | -7.53% | 3.60% | 1.55% | 8.18% | |||||
Europe | 328.63M | 280.25M | 253.58M | 246.85M | 241.80M | |||||
Europe Growth | 17.26% | 10.52% | 2.73% | 2.09% | 17.09% | |||||
Asia (Excluding The PRC) | 112.15M | 88.28M | 71.42M | 64.09M | 64.36M | |||||
Asia (Excluding The PRC) Growth | 27.05% | 23.59% | 11.44% | -0.41% | 12.52% | |||||
South America | 46.72M | 33.42M | 22.81M | 12.07M | 9.70M | |||||
South America Growth | 39.79% | 46.50% | 89.09% | 24.41% | 68.72% | |||||
Others | 16.66M | 14.60M | 10.19M | 15.73M | 10.83M | |||||
Others Growth | 14.13% | 43.18% | -35.21% | 45.30% | 421.83% | |||||
Total | 1.11B | 1.03B | 950.73M | 840.83M | 778.64M | |||||
Total Growth | 7.21% | 8.45% | 13.07% | 7.99% | 20.02% |
Source: S&P Global Market Intelligence.